Regeneron Pharma (REGN) PT Lowered to $587 at Baird
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $794.19 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Join SI Premium – FREE
Baird analyst Brian Skorney lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $587.00 (from $652.00) while maintaining a Neutral rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $109 at Raymond James
- Sumco Corp (3436:JP) (SUOPY) PT Lowered to JPY5,500 at Goldman Sachs
- Goldman Sachs Downgrades Mitsubishi Gas Chemical Co Inc (4182:JP) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
